| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |